| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0002-9343(93)90332-J |
| P698 | PubMed publication ID | 8238066 |
| P50 | author | Aaron R. Folsom | Q71098091 |
| P2093 | author name string | Shahar E | |
| Wang SP | |||
| Grayston JT | |||
| Szklo M | |||
| Melnick SL | |||
| Sorlie PD | |||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | atherosclerosis | Q12252367 |
| Chlamydia pneumoniae | Q62869737 | ||
| P304 | page(s) | 499-504 | |
| P577 | publication date | 1993-11-01 | |
| P1433 | published in | American Journal of Medicine | Q2842959 |
| P1476 | title | Past infection by Chlamydia pneumoniae strain TWAR and asymptomatic carotid atherosclerosis. Atherosclerosis Risk in Communities (ARIC) Study Investigators | |
| P478 | volume | 95 |
| Q37871487 | Absence of Chlamydia pneumoniae in surgical specimens of coronary and carotid arteries by polymerase chain reaction |
| Q77230027 | Aggregation of dimyristoylphosphatidylglycerol liposomes by human plasma low density lipoprotein |
| Q39628799 | An analysis of the link between strokes and soils in the South Carolina coastal plains. |
| Q77299120 | An association between periodontal disease and peripheral vascular disease |
| Q43424617 | Antibiotic use and occlusive stroke: weighing a negative result |
| Q24201388 | Antibiotics for secondary prevention of coronary heart disease |
| Q37880719 | Arteriosclerosis as a sequela of chronic Chlamydia pneumoniae infection |
| Q28195798 | Aspirin inhibits Chlamydia pneumoniae-induced NF-κB activation, cyclo-oxygenase-2 expression and prostaglandin E2 synthesis and attenuates chlamydial growth |
| Q37877118 | Association of Chlamydia pneumoniae infection with diabetic nephropathy |
| Q51030319 | Asymptomatic atherosclerosis in HIV-positive patients: A case-control ultrasound study. |
| Q37882083 | Atherosclerosis due to chronic arteritis caused by Chlamydia pneumoniae: a tentative hypothesis |
| Q37873310 | C-reactive protein is increased in patients with degenerative aortic valvular stenosis |
| Q37877470 | Can an antibiotic (macrolide) prevent Chlamydia pneumoniae-induced atherosclerosis in a rabbit model? |
| Q37873100 | Characterization of Chlamydia pneumoniae persistence in HEp-2 cells treated with gamma interferon. |
| Q37881299 | Characterization of a strain of Chlamydia pneumoniae isolated from a coronary atheroma by analysis of the omp1 gene and biological activity in human endothelial cells |
| Q34086738 | Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old) |
| Q35367697 | Chlamydia pneumoniae (TWAR). |
| Q73311061 | Chlamydia pneumoniae and atherosclerosis |
| Q37868049 | Chlamydia pneumoniae and atherosclerosis following carotid endarterectomy. |
| Q33534714 | Chlamydia pneumoniae and atherosclerosis. |
| Q33905858 | Chlamydia pneumoniae and atherosclerosis: critical assessment of diagnostic methods and relevance to treatment studies |
| Q33659387 | Chlamydia pneumoniae and coronary heart disease |
| Q37881193 | Chlamydia pneumoniae and its role in chronic obstructive pulmonary disease |
| Q37880994 | Chlamydia pneumoniae and occlusive vascular disease: identification and characterization |
| Q37880177 | Chlamydia pneumoniae and vascular disease |
| Q37228857 | Chlamydia pneumoniae in atheroma: consideration of criteria for causality |
| Q37878142 | Chlamydia pneumoniae infection and ethnic origin |
| Q37879407 | Chlamydia pneumoniae infection is frequent but not associated with coronary arteriosclerosis in cardiac transplant recipients |
| Q37878378 | Chlamydia pneumoniae infection of human endothelial cells induces proliferation of smooth muscle cells via an endothelial cell-derived soluble factor(s). |
| Q37861022 | Chlamydia pneumoniae replicates in Kupffer cells in mouse model of liver infection |
| Q37871330 | Chlamydia pneumoniae seropositivity and early carotid atherosclerosis in a suburban Japanese population |
| Q37865328 | Chlamydia pneumoniae seropositivity and risk of ischemic stroke: a nested case-control study |
| Q35121619 | Chlamydia pneumoniae seropositivity in adults with acute ischemic stroke: A case-control study |
| Q33821294 | Chlamydia pneumoniae: defining the clinical spectrum of infection requires precise laboratory diagnosis |
| Q36838445 | Chlamydiae as pathogens: new species and new issues |
| Q37869989 | Chlamydial LPS antibodies, intima-media thickness and ischemic events in patients with established atherosclerosis |
| Q37870867 | Chronic Chlamydia pneumoniae infection in patients with coronary disease. Relation with increased fibrinogen values |
| Q33843633 | Chronic infection and coronary artery disease |
| Q79299394 | Chronic infection and coronary artery disease |
| Q37882065 | Chronic infection in the etiology of atherosclerosis--the case for Chlamydia pneumoniae |
| Q37838935 | Comparative genomic analysis of human Chlamydia pneumoniae isolates from respiratory, brain and cardiac tissues |
| Q37877605 | De Novo induction of atherosclerosis by Chlamydia pneumoniae in a rabbit model. |
| Q36541516 | Detection of Chlamydia pneumoniae but not Helicobacter pylori in atherosclerotic plaques of aortic aneurysms |
| Q37864671 | Development of a hamster model of Chlamydophila pneumoniae infection. |
| Q37871079 | Early impairment of coronary flow reserve is not associated with Chlamydia pneumoniae antibodies |
| Q35091533 | Effect of PEX, a noncatalytic metalloproteinase fragment with integrin-binding activity, on experimental Chlamydophila pneumoniae infection |
| Q37869882 | Effect of short-term antibiotic treatment on Chlamydia pneumoniae and peripheral endothelial function. |
| Q40968088 | Effects of fluoroquinolones on the migration of human phagocytes through Chlamydia pneumoniae-infected and tumor necrosis factor alpha-stimulated endothelial cells |
| Q35110637 | Effects of two antibiotic regimens on course and persistence of experimental Chlamydia pneumoniae TWAR pneumonitis |
| Q37879484 | Endovascular presence of Chlamydia pneumoniae DNA is a generalized phenomenon in atherosclerotic vascular disease |
| Q37882356 | Endovascular presence of Chlamydia pneumoniae in patients with hemodynamically effective carotid artery stenosis |
| Q33762140 | Epidemiology of Chlamydia pneumoniae in atherosclerosis |
| Q35799740 | Epidemiology of transient ischemic attack and ischemic stroke in patients with underlying cardiovascular disease. |
| Q34562273 | Evidence for infectious agents in cardiovascular disease and atherosclerosis |
| Q37887313 | Experimental Chlamydia pneumoniae infection in mice: effect of reinfection and passive immunization |
| Q37867617 | Experimental infection by Chlamydia pneumoniae in the hamster |
| Q35774105 | Experimental rabbit models of Chlamydia pneumoniae infection |
| Q26751807 | Fifty years of stroke researches in India |
| Q33821315 | Helicobacter pylori, Chlamydia pneumoniae, and cytomegalovirus: chronic infections and coronary heart disease |
| Q37868665 | Hepatitis A IgG seropositivity and coronary atherosclerosis assessed by angiography |
| Q34605079 | Hepatitis B virus infection and coronary atherosclerosis: results from a population with relatively high prevalence of hepatitis B virus. |
| Q37869178 | High prevalence of Chlamydia pneumoniae antibodies in white-coat hypertensives |
| Q37878292 | Immunoglobulin A antibodies against Chlamydia pneumoniae are associated with expansion of abdominal aortic aneurysm. |
| Q34015063 | Immunological basis of Chlamydia induced reactive arthritis |
| Q44676662 | Increase of inflammatory state in overweight adults with combined hyperlipidemia. |
| Q37870220 | Increased prevalence of Chlamydophila pneumoniae but not Epstein-Barr antibodies in essential hypertensives |
| Q37879018 | Infection of human endothelial cells with Chlamydia pneumoniae stimulates transendothelial migration of neutrophils and monocytes |
| Q33921219 | Infections and atherosclerosis |
| Q35165193 | Inflammation, infection, and atherosclerosis |
| Q33603398 | Is cardiovascular disease preventable by vaccination? |
| Q37869460 | Lack of association between Chlamydia pneumoniae seropositivity and aortic atherosclerotic plaques: a population-based transesophageal echocardiographic study |
| Q37877681 | Lack of association between seropositivity to Chlamydia pneumoniae and carotid atherosclerosis. |
| Q37856198 | Microbial risk factors of cardiovascular and cerebrovascular diseases: potential therapeutical options |
| Q34065709 | Microorganisms in the aetiology of atherosclerosis. |
| Q92778410 | No Association Found Between Midlife Seropositivity for Infection and Subsequent Cognitive Decline: The Atherosclerosis Risk in Communities Neurocognitive Study (ARIC-NCS) |
| Q77124527 | Paraoxonase activity in the serum and hepatic mRNA levels decrease during the acute phase response |
| Q37879499 | Pathogenesis of atherosclerosis: a possible relation to infection |
| Q36177627 | Place of drug therapy in the treatment of carotid stenosis |
| Q37883934 | Rabbit model for Chlamydia pneumoniae infection |
| Q37866100 | Relationship between the peripheral arterial occlusive disease and the infection by Chlamydophila pneumoniae |
| Q37876249 | Requirement for NF-kappaB in transcriptional activation of monocyte chemotactic protein 1 by Chlamydia pneumoniae in human endothelial cells |
| Q34698619 | Review of evidence for a connection between Chlamydia pneumoniae and atherosclerotic disease |
| Q59050542 | Role of Interleukin-6 Correlated toC. pneumoniaeInfection as a Biomarker for Prediction of Stroke Severity in Young Patients with Acute Ischemic Stroke |
| Q37879495 | Seroepidemiological evidence for an association between Chlamydia pneumoniae and atherosclerosis |
| Q37853986 | Seroprevalence of Chlamydia pneumoniae antibodies in stroke in young. |
| Q35764383 | Specificity of detection of Chlamydia pneumoniae in cardiovascular atheroma: evaluation of the innocent bystander hypothesis |
| Q37875919 | T lymphocyte lines isolated from atheromatous plaque contain cells capable of responding to Chlamydia antigens. |
| Q34557697 | The role of inflammatory and immunological mediators in periodontitis and cardiovascular disease |
| Q34447107 | The role of risk factors in the development of atherosclerosis |
| Q37873368 | The significance of Chlamydia pneumoniae in symptomatic carotid stenosis |
| Q34067823 | The use of serologic tests for the diagnosis of chlamydial infections |
| Q36480698 | Thematic review series: patient-oriented research. Imaging atherosclerosis: state of the art. |
| Q37799367 | Why should a doctor be interested in oral disease? |
Search more.